# Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTP

> **NCT04985318** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Cologne** · enrollment: 350 (estimated)

## Conditions studied

- Acquired Thrombotic Thrombocytopenic Purpura

## Interventions

- **DRUG:** Cablivi®

## Key facts

- **NCT ID:** NCT04985318
- **Lead sponsor:** University of Cologne
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-03-25
- **Primary completion:** 2034-12-12
- **Final completion:** 2034-12-12
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04985318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04985318, "Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTP". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04985318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*